[KLK] YoY Cumulative Quarter Result on 30-Jun-2020 [#3]

Announcement Date
19-Aug-2020
Admission Sponsor
-
Sponsor
-
Financial Year
30-Sep-2020
Quarter
30-Jun-2020 [#3]
Profit Trend
QoQ- 188.99%
YoY- 27.41%
View:
Show?
Cumulative Result
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Revenue 17,870,276 20,172,770 13,981,263 11,592,548 11,731,484 14,209,524 15,840,254 2.02%
PBT 969,408 2,492,088 2,096,471 849,440 577,190 947,190 1,069,403 -1.62%
Tax -147,490 -591,828 -340,062 -231,678 -121,325 -246,666 -268,376 -9.49%
NP 821,918 1,900,260 1,756,409 617,762 455,865 700,524 801,027 0.42%
-
NP to SH 717,951 1,704,160 1,631,784 563,788 442,486 651,828 763,006 -1.00%
-
Tax Rate 15.21% 23.75% 16.22% 27.27% 21.02% 26.04% 25.10% -
Total Cost 17,048,358 18,272,510 12,224,854 10,974,786 11,275,619 13,509,000 15,039,227 2.11%
-
Net Worth 14,461,826 13,509,295 12,047,315 10,752,433 10,489,912 11,235,388 11,341,884 4.13%
Dividend
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Div 215,687 215,631 215,708 161,771 159,744 159,744 159,744 5.12%
Div Payout % 30.04% 12.65% 13.22% 28.69% 36.10% 24.51% 20.94% -
Equity
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Net Worth 14,461,826 13,509,295 12,047,315 10,752,433 10,489,912 11,235,388 11,341,884 4.13%
NOSH 1,081,017 1,081,017 1,081,017 1,081,017 1,064,965 1,064,965 1,064,965 0.24%
Ratio Analysis
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
NP Margin 4.60% 9.42% 12.56% 5.33% 3.89% 4.93% 5.06% -
ROE 4.96% 12.61% 13.54% 5.24% 4.22% 5.80% 6.73% -
Per Share
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
RPS 1,657.05 1,871.04 1,296.31 1,074.90 1,101.58 1,334.27 1,487.40 1.81%
EPS 66.60 158.10 151.30 52.60 41.50 61.20 71.60 -1.19%
DPS 20.00 20.00 20.00 15.00 15.00 15.00 15.00 4.90%
NAPS 13.41 12.53 11.17 9.97 9.85 10.55 10.65 3.91%
Adjusted Per Share Value based on latest NOSH - 1,081,017
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
RPS 1,626.07 1,835.58 1,272.20 1,054.84 1,067.48 1,292.97 1,441.35 2.02%
EPS 65.33 155.07 148.48 51.30 40.26 59.31 69.43 -1.00%
DPS 19.63 19.62 19.63 14.72 14.54 14.54 14.54 5.12%
NAPS 13.1592 12.2925 10.9622 9.784 9.5451 10.2234 10.3203 4.13%
Price Multiplier on Financial Quarter End Date
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Date 30/06/23 30/06/22 30/06/21 30/06/20 28/06/19 29/06/18 30/06/17 -
Price 21.96 21.94 20.36 22.20 24.56 24.16 24.88 -
P/RPS 1.33 1.17 1.57 2.07 2.23 1.81 1.67 -3.72%
P/EPS 32.99 13.88 13.46 42.47 59.11 39.47 34.73 -0.85%
EY 3.03 7.20 7.43 2.35 1.69 2.53 2.88 0.84%
DY 0.91 0.91 0.98 0.68 0.61 0.62 0.60 7.18%
P/NAPS 1.64 1.75 1.82 2.23 2.49 2.29 2.34 -5.74%
Price Multiplier on Announcement Date
30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 CAGR
Date 24/08/23 17/08/22 18/08/21 19/08/20 20/08/19 14/08/18 15/08/17 -
Price 22.40 23.00 19.88 22.60 23.82 24.86 24.68 -
P/RPS 1.35 1.23 1.53 2.10 2.16 1.86 1.66 -3.38%
P/EPS 33.65 14.55 13.14 43.23 57.33 40.62 34.45 -0.39%
EY 2.97 6.87 7.61 2.31 1.74 2.46 2.90 0.39%
DY 0.89 0.87 1.01 0.66 0.63 0.60 0.61 6.49%
P/NAPS 1.67 1.84 1.78 2.27 2.42 2.36 2.32 -5.32%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment